Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited (ADVENZYMES) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Biotechnology

advancedenzymes.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-09-03

Stock price
₹296.00
Market cap
3,317 Cr
Stock P/E
19.5
P/B
1.97
Dividend yield
1.8%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales158 Cr161 Cr158 Cr155 Cr146 Cr169 Cr167 Cr186 Cr185 Cr172 Cr203 Cr190 Cr
Operating expenses (approx.)107 Cr107 Cr102 Cr103 Cr104 Cr114 Cr122 Cr129 Cr124 Cr123 Cr140 Cr139 Cr
EBITDA51 Cr54 Cr55 Cr51 Cr42 Cr55 Cr46 Cr56 Cr60 Cr49 Cr63 Cr51 Cr
OPM %32.5%33.4%35.1%33.1%29.0%32.7%27.3%30.4%32.5%28.7%31.1%26.9%
Other income6 Cr14 Cr9 Cr7 Cr10 Cr8 Cr9 Cr9 Cr10 Cr8 Cr7 Cr13 Cr
Interest0.75 Cr0.68 Cr0.85 Cr0.87 Cr0.93 Cr0.94 Cr0.81 Cr0.76 Cr0.72 Cr0.57 Cr0.57 Cr0.58 Cr
Depreciation9 Cr9 Cr9 Cr9 Cr9 Cr9 Cr10 Cr10 Cr10 Cr10 Cr10 Cr10 Cr
Profit before tax48 Cr59 Cr40 Cr49 Cr42 Cr53 Cr43 Cr55 Cr60 Cr58 Cr60 Cr54 Cr
Tax %26.6%27.8%24.6%28.1%20.9%26.7%38.5%26.3%24.9%25.9%24.3%27.9%
Net profit35 Cr43 Cr30 Cr35 Cr33 Cr39 Cr27 Cr40 Cr45 Cr43 Cr45 Cr39 Cr
EPS (₹)₹3.08₹3.74₹2.53₹3.05₹2.94₹3.36₹2.37₹3.57₹3.87₹3.80₹3.84₹3.31

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales420 Cr444 Cr502 Cr529 Cr541 Cr624 Cr637 Cr746 CrSign in for TTM
Operating expenses (approx.)238 Cr242 Cr270 Cr328 Cr384 Cr419 Cr442 Cr517 CrSign in for TTM
EBITDA182 Cr202 Cr232 Cr201 Cr156 Cr204 Cr194 Cr229 CrSign in for TTM
OPM %43.4%45.6%46.1%38.0%28.9%32.8%30.5%30.7%Sign in for TTM
Other income5 Cr6 Cr9 Cr6 Cr25 Cr37 Cr33 Cr35 CrSign in for TTM
Interest4 Cr3 Cr2 Cr2 Cr2 Cr3 Cr4 Cr3 CrSign in for TTM
Depreciation21 Cr26 Cr28 Cr35 Cr35 Cr35 Cr37 Cr40 CrSign in for TTM
Profit before tax162 Cr179 Cr210 Cr171 Cr140 Cr188 Cr187 Cr233 CrSign in for TTM
Tax %28.4%25.7%28.0%27.6%26.0%27.1%28.5%25.3%Sign in for TTM
Net profit116 Cr133 Cr151 Cr124 Cr104 Cr137 Cr134 Cr174 CrSign in for TTM
EPS (₹)₹9.95₹11.58₹13.09₹10.70₹9.45₹11.92₹11.72₹15.08Sign in for TTM
Dividend payout %———0.0%12.1%41.4%44.1%34.4%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital22 Cr22 Cr22 Cr22 Cr22 Cr22 Cr22 Cr22 Cr
Reserves657 Cr817 Cr948 Cr1,066 Cr1,213 Cr1,302 Cr1,398 Cr1,610 Cr
Borrowings28 Cr17 Cr15 Cr11 Cr13 Cr25 Cr22 Cr21 Cr
Other liabilities78 Cr94 Cr107 Cr116 Cr124 Cr139 Cr131 Cr135 Cr
Total liabilities811 Cr979 Cr1,153 Cr1,268 Cr1,422 Cr1,535 Cr1,621 Cr1,839 Cr
Fixed assets (net)162 Cr210 Cr238 Cr262 Cr273 Cr277 Cr293 Cr276 Cr
CWIP5 Cr5 Cr5 Cr10 Cr16 Cr31 Cr22 Cr51 Cr
Investments111 Cr124 Cr121 Cr102 Cr360 Cr403 Cr480 Cr584 Cr
Loans & advances0.13 Cr0.07 Cr0.09 Cr0.09 Cr0.12 Cr0.10 Cr0.10 Cr0.24 Cr
Inventories77 Cr80 Cr94 Cr121 Cr124 Cr148 Cr157 Cr177 Cr
Trade receivables59 Cr75 Cr86 Cr88 Cr100 Cr99 Cr115 Cr145 Cr
Cash & bank23 Cr83 Cr192 Cr267 Cr96 Cr114 Cr94 Cr109 Cr
Other assets375 Cr403 Cr416 Cr417 Cr452 Cr464 Cr459 Cr497 Cr
Total assets811 Cr979 Cr1,153 Cr1,268 Cr1,422 Cr1,535 Cr1,621 Cr1,839 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity———124 Cr140 Cr141 Cr142 Cr157 Cr
Cash from investing———-26 Cr-298 Cr-65 Cr-89 Cr-74 Cr
Cash from financing———-27 Cr-26 Cr-59 Cr-73 Cr-70 Cr
Net cash flow———75 Cr-171 Cr17 Cr-20 Cr15 Cr
Free cash flow (OCF − Capex)———95 Cr102 Cr94 Cr108 Cr104 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %24.4%21.7%21.8%15.9%11.0%13.7%12.8%13.8%
ROE %16.4%15.4%15.1%11.0%8.2%9.7%8.9%10.0%
Debtor days5161636168586671
Inventory days426322341338354349354332
Days payable5439555069373975
Cash conversion cycle423345348349352369381328
Debt / equity0.000.000.000.000.010.020.020.01
Current ratio4.336.317.6410.009.317.619.099.78
Net debt / EBITDA0.000.000.000.00-0.53-0.43-0.37-0.39

Compare with peers

Loading peers…